DK1501828T3 - Piperazinbenzothiazoler som midler til behandling af cerebrale iskæmiske lidelser eller CNS-lidelser - Google Patents
Piperazinbenzothiazoler som midler til behandling af cerebrale iskæmiske lidelser eller CNS-lidelserInfo
- Publication number
- DK1501828T3 DK1501828T3 DK03727365T DK03727365T DK1501828T3 DK 1501828 T3 DK1501828 T3 DK 1501828T3 DK 03727365 T DK03727365 T DK 03727365T DK 03727365 T DK03727365 T DK 03727365T DK 1501828 T3 DK1501828 T3 DK 1501828T3
- Authority
- DK
- Denmark
- Prior art keywords
- piperazine
- treatment
- benzothiazoles
- agents
- cerebral ischemic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02100417 | 2002-04-25 | ||
PCT/EP2003/004323 WO2003091249A1 (en) | 2002-04-25 | 2003-04-25 | Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1501828T3 true DK1501828T3 (da) | 2008-03-10 |
Family
ID=29265991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03727365T DK1501828T3 (da) | 2002-04-25 | 2003-04-25 | Piperazinbenzothiazoler som midler til behandling af cerebrale iskæmiske lidelser eller CNS-lidelser |
Country Status (23)
Country | Link |
---|---|
US (1) | US7314878B2 (pt) |
EP (1) | EP1501828B1 (pt) |
JP (1) | JP4523289B2 (pt) |
KR (1) | KR100948469B1 (pt) |
CN (1) | CN1310911C (pt) |
AT (1) | ATE383356T1 (pt) |
AU (1) | AU2003233067B2 (pt) |
BR (1) | BRPI0309594A8 (pt) |
CA (1) | CA2481763C (pt) |
CY (1) | CY1107204T1 (pt) |
DE (1) | DE60318567T2 (pt) |
DK (1) | DK1501828T3 (pt) |
EA (1) | EA009682B1 (pt) |
ES (1) | ES2297165T3 (pt) |
HK (1) | HK1075664A1 (pt) |
IL (2) | IL164796A0 (pt) |
MX (1) | MXPA04010474A (pt) |
PT (1) | PT1501828E (pt) |
RS (1) | RS51407B (pt) |
SI (1) | SI1501828T1 (pt) |
UA (1) | UA78035C2 (pt) |
WO (1) | WO2003091249A1 (pt) |
ZA (1) | ZA200408023B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60318567T2 (de) | 2002-04-25 | 2009-02-19 | Laboratoires Serono S.A., Coinsins | Piperazinbenzothiazole als wirkstoffe in der behandlung von ischämien und krankheiten des zns-systems |
PT1696909E (pt) * | 2003-09-12 | 2007-12-21 | Serono Lab | Derivados benzotiazolo para o tratamento de diabetes |
WO2005118543A1 (ja) * | 2004-06-03 | 2005-12-15 | Ono Pharmaceutical Co., Ltd. | キナーゼ阻害薬およびその用途 |
US7838522B2 (en) | 2004-11-17 | 2010-11-23 | Ares Trading S.A. | Benzothiazole formulations and use thereof |
ES2315931T3 (es) * | 2004-11-17 | 2009-04-01 | Ares Trading S.A. | Formulaciones de benzotiazol y su uso. |
KR20080044836A (ko) | 2005-07-15 | 2008-05-21 | 라보라뚜와르 세로노 에스. 에이. | 자궁내막증 치료용 jnk 억제제 |
BRPI0613042A2 (pt) * | 2005-07-15 | 2010-12-14 | Serono Lab | inibidores de jnk para o tratamento de endometriose |
US20100121057A1 (en) * | 2007-04-17 | 2010-05-13 | Merck Serono Sa | Process for the Preparation of Piperazine Benzothiazoles |
RU2504545C2 (ru) * | 2008-05-16 | 2014-01-20 | Ф. Хоффманн-Ля Рош Аг | Ингибиторы jnk |
KR101800916B1 (ko) * | 2010-06-04 | 2017-11-23 | 에프. 호프만-라 로슈 아게 | Jnk 억제제로서 유용한 2-아미노-피리미딘 유도체 |
US8471027B2 (en) * | 2011-04-06 | 2013-06-25 | Hoffmann-La Roche Inc. | Adamantyl compounds |
CN104903331A (zh) * | 2013-01-24 | 2015-09-09 | 山东亨利医药科技有限责任公司 | Jnk抑制剂 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4153574B2 (ja) * | 1997-09-10 | 2008-09-24 | トーアエイヨー株式会社 | 新規なピペリジン誘導体、その製造法およびそれを含有する循環器官用剤 |
EP1110957A1 (en) * | 1999-12-24 | 2001-06-27 | Applied Research Systems ARS Holding N.V. | Benzazole derivatives and their use as JNK modulators |
EP1193256A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins |
DE60318567T2 (de) | 2002-04-25 | 2009-02-19 | Laboratoires Serono S.A., Coinsins | Piperazinbenzothiazole als wirkstoffe in der behandlung von ischämien und krankheiten des zns-systems |
-
2003
- 2003-04-25 DE DE60318567T patent/DE60318567T2/de not_active Expired - Lifetime
- 2003-04-25 PT PT03727365T patent/PT1501828E/pt unknown
- 2003-04-25 KR KR1020047016871A patent/KR100948469B1/ko not_active IP Right Cessation
- 2003-04-25 UA UA20041008647A patent/UA78035C2/uk unknown
- 2003-04-25 SI SI200331114T patent/SI1501828T1/sl unknown
- 2003-04-25 ES ES03727365T patent/ES2297165T3/es not_active Expired - Lifetime
- 2003-04-25 CA CA2481763A patent/CA2481763C/en not_active Expired - Fee Related
- 2003-04-25 US US10/511,438 patent/US7314878B2/en not_active Expired - Lifetime
- 2003-04-25 MX MXPA04010474A patent/MXPA04010474A/es active IP Right Grant
- 2003-04-25 IL IL16479603A patent/IL164796A0/xx unknown
- 2003-04-25 CN CNB03814493XA patent/CN1310911C/zh not_active Expired - Fee Related
- 2003-04-25 AU AU2003233067A patent/AU2003233067B2/en not_active Ceased
- 2003-04-25 RS YUP-928/04A patent/RS51407B/en unknown
- 2003-04-25 EP EP03727365A patent/EP1501828B1/en not_active Expired - Lifetime
- 2003-04-25 WO PCT/EP2003/004323 patent/WO2003091249A1/en active IP Right Grant
- 2003-04-25 BR BRPI0309594A patent/BRPI0309594A8/pt not_active IP Right Cessation
- 2003-04-25 DK DK03727365T patent/DK1501828T3/da active
- 2003-04-25 JP JP2003587807A patent/JP4523289B2/ja not_active Expired - Fee Related
- 2003-04-25 AT AT03727365T patent/ATE383356T1/de active
- 2003-04-25 EA EA200401423A patent/EA009682B1/ru not_active IP Right Cessation
- 2003-04-25 IL IL164796A patent/IL164796A/en not_active IP Right Cessation
-
2004
- 2004-10-05 ZA ZA2004/08023A patent/ZA200408023B/en unknown
-
2005
- 2005-11-10 HK HK05110023A patent/HK1075664A1/xx not_active IP Right Cessation
-
2008
- 2008-02-18 CY CY20081100199T patent/CY1107204T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1075664A1 (en) | Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders | |
DK1789398T3 (da) | 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE) | |
DE60332433D1 (de) | Azolylaminoazine als proteinkinasehemmer | |
DE60332604D1 (de) | Azolylaminoazine als proteinkinasehemmer | |
DK1776349T3 (da) | 2-amino-puinazolin derivater anvendelige som inhibitorer af beta-sekretase (BACE) | |
DE60314603D1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
NO20052595L (no) | Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser. | |
DK1242415T3 (da) | 3-thiazol-4-yl-pyrolidinderivater som AMP-specifikke phosphodiesteraseinhibitorer | |
NO20050514L (no) | Sammensetning og antiviral aktivitet til substituerte azaindoloksoeddikpiperazinderivater | |
ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
NO20054848L (no) | Substituerte p-diaminobenzenderivater | |
NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
UY30025A1 (es) | Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
DE602004024572D1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
NO20050701L (no) | 4-pyrrolidino-fenyl-benzyleter derivater | |
ECSP055844A (es) | Nuevos compuestos triciclicos | |
DE602004012578D1 (de) | Als inhibitoren von c-met geeignete pyrrolzusammensetzungen | |
NO20082679L (no) | Sammensetning og fremgangsmate for a behandle CNS lidelser | |
NO20054721L (no) | Substituerte anilinderivater | |
ATE440836T1 (de) | Verbindungen | |
DK1751105T3 (da) | Piperazinderivater af alkyloxindoler | |
NO20050146L (no) | N,N-disubstituerte diazocykloalkaner nyttige i behandling av CNS-forstyrrelser grunnet serotonergisk dysfunksjon |